FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida The peptide problem: Hype is outrunning the evidence The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype